CurrentEndo coverage · page 27 of 33

Cardiovascular Diabetology

Briefs 1,041–1,080 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol8 Nov 2023
Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension
Cohort study
Cardiovasc Diabetol8 Nov 2023
Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: analysis of the MIMIC-IV database
Cohort study
Cardiovasc Diabetol8 Nov 2023
Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database
Cohort study
Cardiovasc Diabetol8 Nov 2023
Roles of gut microbiota in atrial fibrillation: insights from Mendelian randomization analysis and genetic data from over 430,000 cohort study participants
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol3 Nov 2023
Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation
Mechanistic studyComplications
Cardiovasc Diabetol2 Nov 2023
Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells
Cross-sectional studyT2D & other
Cardiovasc Diabetol2 Nov 2023
Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy
Cross-sectional studyT2D & other
Cardiovasc Diabetol2 Nov 2023
High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies
Meta-analysisT1D
Cardiovasc Diabetol2 Nov 2023
Relationship between the circulating N-terminal pro B-type natriuretic peptide and the risk of carotid artery plaque in different glucose metabolic states in patients with coronary heart disease: a CSCD-TCM plus study in China
Cross-sectional studyT2D & other
Cardiovasc Diabetol30 Oct 2023
Association between high sensitivity cardiac troponin and mortality risk in the non-diabetic population: findings from the National Health and Nutrition Examination Survey
Cohort studyT2D & other
Cardiovasc Diabetol30 Oct 2023
FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus
Cross-sectional studyComplications
Cardiovasc Diabetol30 Oct 2023
Assessment of left atrioventricular coupling and left atrial function impairment in diabetes with and without hypertension using CMR feature tracking
Cross-sectional studyT2D & other
Cardiovasc Diabetol27 Oct 2023
Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
Meta-analysisT2D & other
Cardiovasc Diabetol27 Oct 2023
The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease
Cohort studyLipids & liver
Cardiovasc Diabetol27 Oct 2023
High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study
Cohort study
Cardiovasc Diabetol27 Oct 2023
Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study
Cohort studyT2D & other
Cardiovasc Diabetol27 Oct 2023
C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year postpartum in women with gestational diabetes
Secondary analysisDiabetes in pregnancy
Cardiovasc Diabetol27 Oct 2023
Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease
Mechanistic studyComplications
Cardiovasc Diabetol27 Oct 2023
Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
Secondary analysisT2D & other
Cardiovasc Diabetol27 Oct 2023
Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention
Cohort study
Cardiovasc Diabetol21 Oct 2023
Non-invasive detection of early microvascular changes in juveniles with type 1 diabetes
Cross-sectional studyT1D
Cardiovasc Diabetol21 Oct 2023
Triglyceride-glucose index is associated with severe obstructive coronary artery disease and atherosclerotic target lesion failure among young adults
Case-control study
Cardiovasc Diabetol21 Oct 2023
Familial co-aggregation and shared genetics of cardiometabolic disorders and traits: data from the multi-generational Lifelines Cohort Study
Cohort studyT2D & other
Cardiovasc Diabetol21 Oct 2023
Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention
Cohort studyT2D & other
Cardiovasc Diabetol21 Oct 2023
Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from american MIMIC-IV and the chinese CIN-II study
Cohort studyComplications
Cardiovasc Diabetol17 Oct 2023
Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach
Mechanistic studyT2D & other
Cardiovasc Diabetol17 Oct 2023
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
Research articleT2D & other
Cardiovasc Diabetol17 Oct 2023
The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018
Cohort studyT2D & other
Cardiovasc Diabetol13 Oct 2023
Prognostic significance of the stress hyperglycemia ratio in critically ill patients
Cohort studyComplications
Cardiovasc Diabetol10 Oct 2023
Prognostic significance of plasma SDF-1 in acute ischemic stroke patients with diabetes mellitus: the CATIS trial
Secondary analysisT2D & other
Cardiovasc Diabetol5 Oct 2023
Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
Cohort studyT2D & other
Cardiovasc Diabetol4 Oct 2023
Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol4 Oct 2023
Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study
Cohort studyT2D & other
Cardiovasc Diabetol4 Oct 2023
Association between a mediterranean lifestyle and Type 2 diabetes incidence: a prospective UK biobank study
Cohort studyT2D & other
Cardiovasc Diabetol30 Sep 2023
Elevated high-sensitivity C-reactive protein levels increase the risk of new-onset cardiac conduction disorders
Cohort study
Cardiovasc Diabetol30 Sep 2023
Timing of SGLT2i initiation after acute myocardial infarction
Secondary analysisT2D & other
Cardiovasc Diabetol29 Sep 2023
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol29 Sep 2023
Temporal trends and outcomes of heart transplantation in Spain (2002–2021): propensity score matching analysis to compare patients with and without type 2 diabetes
Cohort studyT2D & other
Cardiovasc Diabetol29 Sep 2023
The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016
Cohort studyT2D & other
Cardiovasc Diabetol29 Sep 2023
High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction
Cohort study

All 1,291 Briefs in ExploreShowing Briefs 1,041–1,080 of 1,291, newest first